Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
XDA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.58.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.58.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.58.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.58.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used